source
- FDA approves Regeneron's Livsayis, first RNAi therapy for generalized myasthenia gravisThe Food and Drug Administration approved Regeneron's Livsayis, an RNA interference drug for generalized myasthenia gravis, marking the company's first marketed RNAi therapy. The drug, originally…
- Grand Strand Sandwich Co. recalls four Lunch Box sandwich products over Listeria riskGrand Strand Sandwich Company Inc. announced a recall of four Lunch Box sandwich items because they may be contaminated with Listeria monocytogenes. The recalled products are the Chicken Sausage B…